Literature DB >> 32392488

Transmission of coronavirus by nebulizer: a serious, underappreciated risk.

Israel Amirav1, Michael T Newhouse2.   

Abstract

Entities:  

Year:  2020        PMID: 32392488      PMCID: PMC7124163          DOI: 10.1503/cmaj.75066

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

Review 1.  Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.

Authors:  C J Cates; J A Crilly; B H Rowe
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

2.  Communication, transparency key as Canada faces new coronavirus threat.

Authors:  Wendy Glauser
Journal:  CMAJ       Date:  2020-02-18       Impact factor: 8.262

Review 3.  Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises.

Authors:  J W Tang; Y Li; I Eames; P K S Chan; G L Ridgway
Journal:  J Hosp Infect       Date:  2006-08-17       Impact factor: 3.926

  3 in total
  18 in total

Review 1.  Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.

Authors:  Krishna Sriram; Rohit Loomba; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

2.  Guidance to physicians on managing asthma during the ongoing pandemic.

Authors:  Raja Dhar; Virendra Singh; J K Samaria; Sundeep Salvi; Deepak Talwar
Journal:  Lung India       Date:  2021-03

Review 3.  The use of nebulized pharmacotherapies during the COVID-19 pandemic.

Authors:  Sanjay Sethi; Igor Z Barjaktarevic; Donald P Tashkin
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

Review 4.  Guideline for the management of COVID-19 patients during hospital admission in a non-intensive care setting.

Authors:  Klaus Nielsen Jeschke; Barbara Bonnesen; Ejvind Frausing Hansen; Jens-Ulrik Stæhr Jensen; Therese Sophie Lapperre; Ulla Møller Weinreich; Ole Hilberg
Journal:  Eur Clin Respir J       Date:  2020-05-28

Review 5.  COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.

Authors:  Marcus S Shaker; John Oppenheimer; Mitchell Grayson; David Stukus; Nicholas Hartog; Elena W Y Hsieh; Nicholas Rider; Cullen M Dutmer; Timothy K Vander Leek; Harold Kim; Edmond S Chan; Doug Mack; Anne K Ellis; David Lang; Jay Lieberman; David Fleischer; David B K Golden; Dana Wallace; Jay Portnoy; Giselle Mosnaim; Matthew Greenhawt
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-26

6.  Risk Communication During COVID-19.

Authors:  Elissa M Abrams; Matthew Greenhawt
Journal:  J Allergy Clin Immunol Pract       Date:  2020-04-15

Review 7.  Asthma and COVID-19: What do we know now.

Authors:  Alexzandra Hughes-Visentin; Anthea B Mahesan Paul
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2020-10-23

8.  A novel mask to prevent aerosol spread during nebulization treatment.

Authors:  Chia-Lung Kao; Chih-Hao Lin
Journal:  J Formos Med Assoc       Date:  2020-08-11       Impact factor: 3.282

9.  Nebulized Therapy in the COVID-19 Era: The Right Tool for the Right Patient [Letter].

Authors:  Michael W Hess
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-09-07

Review 10.  COVID-19; current situation and recommended interventions.

Authors:  Haitham Saeed; Hasnaa Osama; Yasmin M Madney; Hadeer S Harb; Mona A Abdelrahman; Carsten Ehrhardt; Mohamed E A Abdelrahim
Journal:  Int J Clin Pract       Date:  2021-01-14       Impact factor: 3.149

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.